Crescent Biopharma Announces Grants of Inducement Awards
Crescent Biopharma granted inducement awards covering 19,425 ordinary shares to a newly hired non-executive employee. The grants were approved by the compensation committee on July 31, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4). The options carry an exercise price of $14.47 per share, equal to the closing price on the grant date, and have a 10-year term. Vesting schedules provide for one-fourth of the shares to vest on the first anniversary of employment, with the remainder vesting monthly thereafter.
Key figures
- Grant date
- July 31, 2026
- Exercise price
- $14.47
- Options granted
- 19425
- Option term years
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.